Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00476008 · ClinicalTrials.gov registry record · Phase 4
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
A Phase 4 study, sponsored by Florida Atlantic University.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00476008 is a Phase 4 study that has completed, run by Florida Atlantic University. The registered enrollment target is 60 participants.
The verdict
NCT00476008, a Phase 4 study, has completed, sponsored by Florida Atlantic University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether memantine delays the progression of driving impairment in patients with mild Alzheimer's Disease (AD).
Interventions
- DRUG Placebo
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00476008
The ClinicalTrials.gov registry entry for NCT00476008 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00476008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00476008 about?
NCT00476008 is a clinical study titled "Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease". The purpose of the study is to determine whether memantine delays the progression of driving impairment in patients with mild Alzheimer's Disease (AD).
What is the current status of trial NCT00476008?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00476008?
The interventions under investigation include: Placebo (DRUG), Memantine (DRUG).
Who is sponsoring clinical trial NCT00476008?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.